mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.4 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.16 |
0.4 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |